Peking University People's Hospital is the world's largest haploidentical stem cell transplant centre and the home of the Beijing Protocol that lets almost any patient find a donor.
Its Institute of Hematology, led by Huang Xiaojun, developed the Beijing Protocol for haploidentical transplantation without in vitro T-cell depletion (Bone Marrow Transplantation 2006), now the dominant transplant approach in China and adopted by centres elsewhere; it performs more than a thousand transplants a year. Also a major site for CAR-T, leukaemia and lymphoma trials and the hospital's Breast Center and hepatobiliary units.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Peking University People's Hospital, including child institutions. 549 works · 3,578 citations · 75% open access · 9% clinical trials · 3% reviews.
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tag china.
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia and the tag china.
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia and the tag china.
Shares CAR-T cell therapy and the tag china.
Shares Acute myeloid leukaemia and the tag china.
Shares CAR-T cell therapy and the tag china.
Shares CAR-T cell therapy and the tag china.
Shares Acute myeloid leukaemia and the tag china.